エピソード

  • Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies
    2025/09/04
    In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
    続きを読む 一部表示
    13 分
  • New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation
    2025/08/25
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
    続きを読む 一部表示
    12 分
  • The Optic Nerve in Multiple Sclerosis
    2025/02/26
    Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS.
    続きを読む 一部表示
    11 分
  • Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis
    2024/12/11
    In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.
    続きを読む 一部表示
    15 分
  • 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
    2024/11/20
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations.
    続きを読む 一部表示
    10 分
  • 10-year Study Data Shows Reduced Disability in MS Patients Treated with Ocrevus
    2024/07/15
    Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.
    続きを読む 一部表示
    11 分
  • MS Masters Toolbox: Cramps, Spasms, and Spasticity
    2023/09/22
    In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis.
    続きを読む 一部表示
    19 分
  • MS Masters Toolbox: Balance, Gait and Mobility
    2022/08/19
    In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS.
    続きを読む 一部表示
    19 分